Copyright © MARMCJ, All Rights Reserved & Powered By NSM Limited
Associate Professor, Department of Immunology, BIRDEM General Hospital. mansura24@yahoo.com
Dept. of GHPD, Unit-1, BIRDEM General Hospital
Principal Research Officer, Department of Immunology, BIRDEM General Hospital Abdullah Al Mamun Sarker, Senior Research Officer, Department of Immunology, BIRDEM General Hospital.
Senior Research Officer, Department of Immunology, BIRDEM General Hospital.
Senior Research Officer, Department of Immunology, BIRDEM General Hospital,
Resident student MD (Immunology), Department of Immunology, BIRDEM General Hospital
Junior Experimental Officer, Department of Immunology, BIRDEM General Hospital,
Senior Research Officer, Department of Epidemiology & Biostatistics, BIRDEM General Hospital,
Assistant Professor, Department of Immunology, BIRDEM General Hospital. drmonirbirdem@gmail.com.
Keywords: Gastritis, Pepsinogen I, Pepsinogen II, Pepsinogen I/II ratio, Non-invasive biomarker
Background: Inflammation of the stomach mucosa is the hallmark of gastritis, a common gastrointestinal condition that is frequently linked to hormonal, environmental, nutritional, and infectious variables. The gold standard for diagnosis is still endoscopy combined with histological biopsies, but it is invasive, expensive, and not feasible for large-scale screening. Serum pepsinogen levels, particularly the pepsinogen I/II ratio, have been proposed as reliable noninvasive biomarkers for detecting types and severity of gastric mucosal changes.
Objective: The purpose of this study was to assess the serum pepsinogen I/II ratio’s diagnostic value in detecting gastritis patient.
Methods: gastrointestinal endoscopy for dyspeptic symptoms. Serum pepsinogen I and II levels were measured using enzyme-linked immunosorbent assay (ELISA), and the pepsinogen I/II ratio was calculated. Histopathological findings from gastric biopsies were used as the reference standard. Sensitivity, specificity, and diagnostic accuracy of different pepsinogen I and II cut-off values were analyzed.
Results: Among 65 subjects, endoscopy confirmed gastritis in 45 and normal findings in 20. Serum pepsinogen I (279.65 ± 159.82) and pepsinogen II (22.61 ± 17.64) were significantly higher in gastritis patients, with excellent diagnostic accuracy (AUC 0.796 and 0.763, respectively). These results align with previous studies linking elevated pepsinogen I and II to gastritis. In contrast, the pepsinogen I/II ratio showed no significant differences between gastritis subtypes, but in erosive gastritis, most patients showed an increased pepsinogen I/II ratio (>20), whereas in atrophic gastritis, the majority had a decreased ratio (<3).
Conclusion: Serum pepsinogen levels serve as a useful non-invasive marker for gastritis. While the pepsinogen I/II ratio did not show strong utility in this study, broader evidence suggests that it is linked to the risk of both erosive and atrophic gastritis.
Dinajpur Medical College Journal, 2026 Jan; 19 (1):49-58